| Drug Development for Alzheimer’s and Parkinson’s Disease: Where Do We Go Now? L Sequeira, S Benfeito, C Fernandes, I Lima, J Peixoto, C Alves, ... Pharmaceutics 16 (6), 708, 2024 | 4 | 2024 |
| Rescuing a Troubled Tolcapone with PEGylated PLGA Nanoparticles: Design, Characterization, and Hepatotoxicity Evaluation M Pinto, CS Machado, S Barreiro, FJ Otero-Espinar, F Remião, F Borges, ... ACS Applied Materials & Interfaces 16 (17), 21522-21533, 2024 | 3 | 2024 |
| Exploring Nanocarriers for Boosting Entacapone Bioavailability: A Journey through System Characterization and Assessment of Toxicity and Pharmacological and 2D Permeability … CS Machado, M Pinto, B Aguiar, S Costa, B Sarmento, FJ Otero Espinar, ... ACS Applied Materials & Interfaces 16 (43), 58299-58312, 2024 | 2 | 2024 |
| Drug Development for Alzheimer’s and Parkinson’s Disease: Where Do We Go Now? Pharmaceutics 2024, 16, 708 L Sequeira, S Benfeito, C Fernandes, I Lima, J Peixoto, C Alves, ... | | 2024 |
